Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...
Indaptus Therapeutics (INDP) announced the Company has received Clinical Trial Authorization from Health Canada to initiate its clinical trial ...
Health Canada’s approval followed a comprehensive review of our safety data and trial design. Expanding to Canada represents a significant step in our mission to evaluate Decoy20, a broad immune ...
GlobalData on MSN1d
Health Canada approves MSD’s Keytruda for NSCLC stagesHealth Canada has approved MSD's anti-programmed cell death protein 1 (PD-1) therapy Keytruda for treating adults with ...
cbc.ca on MSN9d
Health P.E.I. pays special attention to executive salary levels in developing new leadership modelHealth P.E.I. is moving ahead with plans to rebuild its senior executive team, paying particular attention to salary levels ...
and other community partners announced this week that the Ministry of Health has officially approved a joint Homelessness and Addiction Recovery Treatment (HART) application. The Hub ...
President Trump and Prime Minister Narendra Modi of India were holding a news conference after a private meeting, where, Mr.
cbc.ca on MSN10d
'It changed my life tremendously': P.E.I.'s new ketamine clinic could offer mental health helpHealth Canada approved a prescription esketamine nasal spray called Spravato in 2020 to help with treatment-resistant ...
("Optimi" or the "Company"), a GMP-approved, Health Canada licensed psychedelics pharmaceutical manufacturer specializing in botanical psilocybin and MDMA, announces it has closed the second and ...
Mitchell did mention that current data on some at-home ECG devices indicates a high likelihood of false positive results, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback